1-11 of 11
M. Rodriguez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Initial Clinical Results and Immune Correlates of a Phase 2 Study of Daratumumab, Bortezomib, Dexamethasone Followed By a Proteasome Inhibitor in -Class Transition ( i CT) to Daratumumab, Ixazomib, Dexamethasone in Relapsed Refractory Multiple Myeloma

Hans C. Lee, June Li, Heather Lin, Astrid D. Murga, Gabriela M Rodriguez, Mostafa E. Mohamed, Jared Henderson, Sarah Rodriguez, Melody R. Becnel, Donna M. Weber, Swami P. Iyer, Gregory P. Kaufman, Sheeba K. Thomas, Elisabet E. Manasanch, Krina K. Patel, Stephen J. Noga, Michael R. Green, Robert Z. Orlowski, Cara L Haymaker
Journal: Blood
Blood (2023) 142 (Supplement 1): 4760.
https://doi.org/10.1182/blood-2023-188201
Published: 2023
Journal Articles

Erythrocyte Cytochrome b Reductase 1 Protein Levels and Structure in Sickle Cell Patients

Richard Kulmacz, PhD, Hamidreza Farzaneh, MS, Kathryn L McElhinney, BS, Jose M. Rodriguez, BS, Nicole C. Thomason, BS, Ehsan Irajizad, BE, Vladimir Berka, PhD, Wen Liu, PhD, Modupe Idowu, MD, Harinder S. Juneja, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3654.
https://doi.org/10.1182/blood-2018-99-119885
Published: 2018
Journal Articles

Genomic Variability in Multiple Myeloma (MM) Patients By Race: An Analysis of the Publically Available Mmrf Commpass Study Database

Aneel Paulus, MD, Mayank Sharma, MBBS, Shumail M. Paulus, MBBS, Richa Menghani, MD, Elisa M. Rodriguez, Ryan D Frank, MS, George Cooper, David Hodge, Vivek Roy, MD, Rafael Fonseca, MD, Asher A. Chanan-Khan, MD, Peter Leif Bergsagel, MD, Sikander Ailawadhi, MD
Journal: Blood
Blood (2016) 128 (22): 4432.
https://doi.org/10.1182/blood.V128.22.4432.4432
Published: 2016
Journal Articles

Splenectomy or Rituximab in Steroid-Refractory Immune Thrombocytopenia (ITP): The Mayo Clinic Experience

William A. Hammond, MD, Elisa M. Rodriguez, Zhuo Li, M.S, Bhagirathbhai Dholaria, MBBS, Amanda Shreders, MD, Prakash Vishnu, MD, Candido E. Rivera, MD
Journal: Blood
Blood (2016) 128 (22): 3735.
https://doi.org/10.1182/blood.V128.22.3735.3735
Published: 2016
Journal Articles

The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature

Rebeca Manso, Margarita Sánchez-Beato, Silvia Monsalvo, Sagrario Gómez, Laura Cereceda, Pilar Llamas, Federico Rojo, Manuela Mollejo, Javier Menárguez, Javier Alves, Mónica García-Cosio, Miguel A. Piris, Socorro M. Rodríguez-Pinilla
Journal: Blood
Blood (2014) 123 (18): 2893–2894.
https://doi.org/10.1182/blood-2014-02-555946
Published: 2014
Includes: Supplemental data
Journal Articles

PLCG1 mutations in cutaneous T-cell lymphomas

José P. Vaqué, Gonzalo Gómez-López, Verónica Monsálvez, Ignacio Varela, Nerea Martínez, Cristina Pérez, Orlando Domínguez, Osvaldo Graña, José L. Rodríguez-Peralto, Socorro M. Rodríguez-Pinilla, Carmen González-Vela, Miriam Rubio-Camarillo, Esperanza Martín-Sánchez, David G. Pisano, Evangelia Papadavid, Theodora Papadaki, Luis Requena, José A. García-Marco, Miriam Méndez, Mariano Provencio, Mercedes Hospital, Dolores Suárez-Massa, Concepción Postigo, David San Segundo, Marcos López-Hoyos, Pablo L. Ortiz-Romero, Miguel A. Piris, Margarita Sánchez-Beato
Journal: Blood
Blood (2014) 123 (13): 2034–2043.
https://doi.org/10.1182/blood-2013-05-504308
Published: 2014
Includes: Supplemental data
Journal Articles

PI3K Inhibition As a Potential Therapeutic Strategy in Peripheral T-Cell Lymphomas,

Esperanza Martin-Sanchez, Socorro M. Rodriguez-Pinilla, Luis Lombardia, Beatriz Dominguez-Gonzalez, Margarita Sanchez-Beato, Diana Romero, Magdalena B. Wozniak, Manuela Mollejo, MD, Javier Alves, Jose Luis Rodriguez-Peralto, Javier Menarguez, Juan C. Cigudosa, Pablo L. Ortiz-Romero, Juan F. Garcia, MD, James R. Bischoff, Miguel A. Piris
Journal: Blood
Blood (2011) 118 (21): 3493.
https://doi.org/10.1182/blood.V118.21.3493.3493
Published: 2011
Journal Articles

PIM Kinases Inhibition, a Rational Strategy in Peripheral T-Cell Lymphomas,

Esperanza Martin-Sanchez, Socorro M. Rodriguez-Pinilla, Margarita Sanchez-Beato, Beatriz Dominguez-Gonzalez, Magdalena B. Wozniak, Manuela Mollejo, MD, Javier Alves, Jose Luis Rodriguez-Peralto, Javier Menarguez, Juan C. Cigudosa, Pablo L. Ortiz-Romero, Juan F. Garcia, MD, James R. Bischoff, Miguel A. Piris
Journal: Blood
Blood (2011) 118 (21): 3494.
https://doi.org/10.1182/blood.V118.21.3494.3494
Published: 2011
Journal Articles

PI3KCA and PIM Inhibitors in Peripheral T-Cell Lymphomas

Esperanza Martin-Sanchez, Socorro M. Rodriguez-Pinilla, Luis Lombardia, Margarita Sanchez-Beato, Beatriz Dominguez-Gonzalez, Diana Romero, Cristina I. Gomez-Abad, PierFrancesco Vargiu, Maria E. Rodriguez, Manuela Mollejo, Javier Alves, Magdalena B. Wozniak, James R. Bischoff, Miguel A. Piris
Journal: Blood
Blood (2010) 116 (21): 4917.
https://doi.org/10.1182/blood.V116.21.4917.4917
Published: 2010
Journal Articles

Rituximab, Fludarabine, Mitoxantrone, and Dexamethasone (R-FND) for Relapsed Indolent Lymphomas (RIL).

F.B. Hagemeister, MD, P. McLaughlin, MD, L. Fayad, MD, F. Samaniego, MD, N. Dang, MD, A. Goy, MD, J. Romaguera, MD, B. Pro, MD, V. Beasley, R.N., F. Cabanillas, MD, M. Rodriguez, MD
Journal: Blood
Blood (2005) 106 (11): 941.
https://doi.org/10.1182/blood.V106.11.941.941
Published: 2005
Journal Articles

Efficacy and Safety of Fludarabine/Cyclophosphamide (FC) as Front-Line Treatment of CLL. Final Results of a Phase II Clinical Trial in a Single Center.

Ana Marin-Niebla, MD, Eduardo Rios-Herranz, MD, Juan M. Rodriguez, PhD, Ramiro Nunez, MD, Ascension Herrera, MD, Ricardo Parody, MD, Ildefonso Espigado, PhD.
Journal: Blood
Blood (2004) 104 (11): 4826.
https://doi.org/10.1182/blood.V104.11.4826.4826
Published: 2004